Medtronic PLC
I · Analiza AI
Pe scurt
Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.
Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].
Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.
Scor Sentinellis
5.3/10
Moderate concerns
Capitalizare bursieră
$100.9B
Venituri (12 luni)
$33.5B
II · Știri recente
Ce a mișcat prețul
6 stories · ranked by relevance
- macro2026-05-18
Mental Health Matters at Medtronic. Explore Our Employee Benefits
Yahoo Finance
- macro2026-05-19
Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks
Simply Wall St
- macro2026-05-18
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
Yahoo Finance
- macro2026-05-18
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
Yahoo Finance
- macro2026-05-17
A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years
Yahoo Finance
- macro2026-05-14
Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?
Yahoo Finance
Premium · gratuit cu orice cont
Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]
Riscuri
5
Oportunități
6
Semnale de alarmă
3
Conducere
10
Încă 23 de constatări în raportul complet — gratuit cu orice cont.
Deblochează analiza completă Medtronic PLC
Fă-ți un cont gratuit ca să vezi raportul complet generat de AI, cu surse citate în text.
- 5 riscuri, 6 oportunități și 3 semnale de alarmă — fiecare cu sursa lui
- Peste 100 de indicatori financiari, cu grafice și comparații
- Rezumate complete ale știrilor, cu linkuri către surse
- Echipa de conducere și remunerația
- Export PDF pentru citit offline
III · Companii similare
Ai putea citi și
Same sector · Healthcare or comparable health
Vrei compania asta pe lista ta?